Antibodies blocking PlGF or VEGF interactions with the NRP1 receptor mediate antiproliferative effects
Jennifer A. Maynard(The University of Texas at Austin), Sophie Verrier(Riga Technical University), Martin J. Stoddart(AO Foundation), Kayla G. Sprenger(University of Colorado Boulder), Jangsoon Lee(The University of Texas MD Anderson Cancer Center), Emma C Aldrich(University of Colorado Boulder), Annalee W. Nguyen(The University of Texas at Austin), Ahlam N. Qerqez(The University of Texas at Austin), Nicole V. Johnson(The University of Texas at Austin), Grace Pei‐Chun Lai(The University of Texas at Austin), Alison G. Lee(The University of Texas at Austin)
Cited by 0
Related Papers
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|Science|2020|1.4k
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
|Science Translational Medicine|2021|503
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
|Proceedings of the National Academy of Sciences|2021|379